PRESS RELEASES
<< Back
Xcel Brands, Inc. Announces Second Quarter 2024 Results
- Net income of
$0.2 million for the quarter compared with a net loss of$3.5 million for the prior year quarter, which included a$3.8 million gain on the divestiture of the Lori Goldstein brand. - Net licensing revenues grew 16% from the second quarter of 2023, driven by new licenses and new brand launches.
- Direct Operating Costs and Expenses of
$3.1 million for the quarter, a reduction of$2.1 million or 40% from the prior year’s quarter. - Adjusted EBITDA for the quarter approaches break-even for the quarter, compared with Adjusted EBITDA of negative
$1.3 million for the prior year quarter.
Second Quarter 2024 Financial Results
Total revenue for the second quarter of 2024 was
Net income attributable to
After adjusting for certain cash and non-cash items, results on a non-GAAP basis were a net loss of approximately
Adjusted EBITDA improved significantly on a year-over-year basis to nearly break-even for the current quarter as compared with negative
Six Month 2024 Financial Results
Total revenue for the current six-month period was
Net loss attributable to
After adjusting for certain cash and non-cash items, results on a non-GAAP basis were a net loss of approximately
Adjusted EBITDA improved significantly on a year-over-year basis to negative
Balance Sheet
The Company's balance sheet at
As of
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details at
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
sburroughs@xcelbrands.com
Non-GAAP net income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net income (loss) attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net (loss) income attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results. Adjusted EBITDA is the measure used to calculate compliance with the EBITDA covenant under our term loan agreement.
Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do. In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
Unaudited Condensed Consolidated Statements of Operations | ||||||||||||
(in thousands, except share and per share data) | ||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
Revenues | ||||||||||||
Net licensing revenue | $ | 2,826 | $ | 2,428 | $ | 5,010 | $ | 4,650 | ||||
Net sales | 128 | 4,353 | 128 | 8,181 | ||||||||
Net revenue | 2,954 | 6,781 | 5,138 | 12,831 | ||||||||
Cost of goods sold | 38 | 3,800 | 38 | 6,493 | ||||||||
Gross profit | 2,916 | 2,981 | 5,100 | 6,338 | ||||||||
Operating costs and expenses | ||||||||||||
Salaries, benefits and employment taxes | 1,630 | 2,241 | 3,563 | 5,706 | ||||||||
Other selling, general and administrative expenses | 1,490 | 2,943 | 3,519 | 6,436 | ||||||||
Total operating costs and expenses | 3,120 | 5,184 | 7,082 | 12,142 | ||||||||
Operating loss before other expenses, including non-cash expenses | (204) | (2,203) | (1,982) | (5,804) | ||||||||
Other expense, including non-cash expenses | ||||||||||||
Depreciation and amortization | 1,545 | 1,786 | 3,134 | 3,583 | ||||||||
Loss from equity method investment | 557 | 515 | 1,090 | 1,030 | ||||||||
Asset impairment charges | 1,188 | - | 3,483 | - | ||||||||
Gain on sale of limited partner ownership | - | (351) | - | (351) | ||||||||
Gain on divestiture of |
(3,801) | - | (3,801) | - | ||||||||
Gain on settlement of lease liability | - | (445) | - | (445) | ||||||||
Other expense, including non-cash expenses | (511) | 1,505 | 3,906 | 3,817 | ||||||||
Operating income (loss) | 307 | (3,708) | (5,888) | (9,621) | ||||||||
Interest and finance expense (income), net | 146 | (7) | 296 | 18 | ||||||||
Income (loss) before income taxes | 161 | (3,701) | (6,184) | (9,639) | ||||||||
Income tax provision (benefit) | - | - | - | - | ||||||||
Net income (loss) | 161 | (3,701) | (6,184) | (9,639) | ||||||||
Less: Net loss attributable to noncontrolling interest | (34) | (233) | (85) | (528) | ||||||||
Net income (loss) attributable to |
$ | 195 | $ | (3,468) | $ | (6,099) | $ | (9,111) | ||||
Earnings (loss)per share attributed to |
||||||||||||
Diluted net income (loss) per share | $ | 0.01 | $ | (0.18) | $ | (0.28) | $ | (0.46) | ||||
Basic net income (loss) per share | $ | 0.01 | $ | (0.18) | $ | (0.28) | $ | (0.46) | ||||
Basic weighted average common shares outstanding | 23,491,238 | 19,735,500 | 21,933,079 | 19,684,630 | ||||||||
Diluted weighted average common shares outstanding | 23,539,886 | 19,735,500 | 21,933,079 | 19,684,630 | ||||||||
Unaudited Consolidated Balance Sheets | ||||||
(in thousands, except share and per share data) | ||||||
(unaudited) | ||||||
Assets | ||||||
Current Assets: | ||||||
Cash and cash equivalents | $ | 924 | $ | 2,998 | ||
Accounts receivable, net | 3,055 | 3,454 | ||||
Inventory | 407 | 453 | ||||
Prepaid expenses and other current assets | 378 | 398 | ||||
Total current assets | 4,764 | 7,303 | ||||
Property and equipment, net | 214 | 634 | ||||
Operating lease right-of-use assets | 4,099 | 4,453 | ||||
Trademarks and other intangibles, net | 36,532 | 41,520 | ||||
Equity method investment | 16,643 | 17,735 | ||||
Other assets | 920 | 15 | ||||
Total non-current assets | 58,408 | 64,357 | ||||
Total Assets | $ | 63,172 | $ | 71,660 | ||
Liabilities and Stockholders' Equity | ||||||
Current Liabilities: | ||||||
Accounts payable, accrued expenses and other current liabilities | $ | 2,353 | $ | 2,236 | ||
Deferred revenue | 989 | 889 | ||||
Accrued income taxes payable | 372 | 372 | ||||
Current portion of operating lease obligation | 1,354 | 1,258 | ||||
Current portion of long-term debt | 1,000 | 750 | ||||
Current portion of contingent obligations | — | 964 | ||||
Total current liabilities | 6,068 | 6,469 | ||||
Long-Term Liabilities: | ||||||
Deferred revenue | 3,111 | 3,556 | ||||
Long-term portion of operating lease obligation | 5,964 | 4,021 | ||||
Long-term debt, net, less current portion | 3,524 | 3,971 | ||||
Long-term portion of contingent obligations | — | 5,432 | ||||
Other long-term liabilities | 430 | 40 | ||||
Total long-term liabilities | 13,029 | 17,020 | ||||
Total Liabilities | 19,097 | 23,489 | ||||
Stockholders' Equity: | ||||||
Preferred stock, and outstanding |
- | - | ||||
Common stock, 23,492,117 and 19,795,053 shares issued and outstanding at and |
23 | 20 | ||||
Paid-in capital | 105,946 | 103,861 | ||||
Accumulated deficit | (59,948) | (53,849) | ||||
46,021 | 50,032 | |||||
Noncontrolling interest | (1,946) | (1,861) | ||||
Total Stockholders' Equity | 44,075 | 48,171 | ||||
Total Liabilities and Stockholders' Equity | $ | 63,172 | $ | 71,660 | ||
Unaudited Condensed Consolidated Statements of Cash Flows | ||||||
(in thousands) | ||||||
For the Six Months Ended | ||||||
2024 | 2023 | |||||
Cash flows from operating activities | ||||||
Net income (loss) | $ | (6,184) | $ | (9,639) | ||
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||
Depreciation and amortization expense | 3,134 | 3,583 | ||||
Asset impairment charges | 3,483 | 100 | ||||
Amortization of deferred finance costs | 54 | - | ||||
Stock-based compensation | 186 | 122 | ||||
Provision for (recovery of) credit losses | (45) | - | ||||
Proportional share of trademark amortization of equity method investee | 1,090 | 1,030 | ||||
Gain on divestiture of Lori Goldstein brand | (3,801) | |||||
Gain on sale of limited partner ownership interest | - | (351) | ||||
Gain on settlement of lease liability | - | (445) | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | 444 | (1,768) | ||||
Inventory | 46 | 2,047 | ||||
Prepaid expenses and other assets | (146) | 863 | ||||
Deferred revenue | (345) | 5,041 | ||||
Accounts payable, accrued expenses and other current liabilities | (555) | (1,637) | ||||
Lease-related assets and liabilities | (634) | (417) | ||||
Other Liabilities | 390 | - | ||||
Net cash used in by operating activities | (2,883) | (1,471) | ||||
Cash flows from investing activities | ||||||
Net proceeds from sale of assets | - | 451 | ||||
Purchase of property and equipment | (104) | (81) | ||||
Net cash provided by investing activities | (104) | 370 | ||||
Cash flows from financing activities | ||||||
Proceeds from public offering and private placement transactions, net of transaction costs | 1,902 | - | ||||
Payment of long-term debt | (250) | - | ||||
Payment of breakage fees associated with extinguishment of long-term debt | - | - | ||||
Net cash used in financing activities | 1,652 | - | ||||
Net (decrease) increase in cash, cash equivalents, and restricted cash | (1,335) | (1,101) | ||||
Cash, cash equivalents, and restricted cash at beginning of period | 2,998 | 4,608 | ||||
Cash, cash equivalents, and restricted cash at end of period | $ | 1,663 | $ | 3,507 | ||
Reconciliation to amounts on consolidated balance sheets: | ||||||
Cash and cash equivalents | $ | 924 | $ | 3,507 | ||
Restricted cash (reported in other non-current assets) | 739 | - | ||||
Total cash, cash equivalents, and restricted cash | $ | 1,663 | $ | 3,507 | ||
Supplemental disclosure of non-cash activities: | ||||||
Recognition of operating lease right-of-use asset | $ | 2,596 | $ | - | ||
Recognition of operating lease obligation | $ | 2,596 | $ | - | ||
Supplemental disclosure of cash flow information: | ||||||
Cash paid during the period for interest | $ | 234 | $ | - | ||
Cash paid during the period for income taxes | $ | $ | 16 | |||
($ in thousands) | Three Months Ended |
Six Months Ended |
|||||||||
2024 | 2023 | 2024 | 2023 | ||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||
Net income (loss) attributable to |
$ | 195 | (3,468) | $ | (6,099) | (9,111) | |||||
Amortization of trademarks | 1,520 | 1,525 | 3,039 | 3,045 | |||||||
Loss from equity method investments | 557 | 515 | 1,090 | 1,030 | |||||||
Stock-based compensation | 42 | 65 | 186 | 122 | |||||||
Gain on the sale of assets and investments | (3,801) | (351) | (3,801) | (351) | |||||||
Gain on lease termination | - | (445) | - | (445) | |||||||
Asset impairment | 1,188 | 100 | 3,483 | 100 | |||||||
Non-GAAP net loss | $ | (299) | $ | (2,059) | $ | (2,102) | $ | (5,610) | |||
Three Months Ended |
Six Months Ended |
||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||
Diluted earnings (loss) per share | $ | 0.01 | $ | (0.18) | $ | (0.28) | $ | (0.46) | |||
Amortization of trademarks | 0.07 | 0.08 | 0.14 | 0.15 | |||||||
Loss from equity method investments | 0.02 | 0.03 | 0.05 | 0.05 | |||||||
Stock-based compensation | 0.00 | 0.00 | 0.01 | 0.01 | |||||||
Gain on the sale of assets | (0.16) | (0.01) | (0.17) | (0.01) | |||||||
Gain on lease termination | - | (0.02) | - | (0.02) | |||||||
Asset Impairment | 0.05 | - | 0.15 | - | |||||||
Non-GAAP diluted EPS | $ | (0.01) | $ | (0.10) | $ | (0.10) | $ | (0.28) | |||
Non-GAAP weighted average diluted shares | 23,491,238 | 19,735,500 | 21,933,079 | 19,684,630 | |||||||
($ in thousands) | Three Months Ended |
Six Months Ended |
|||||||||
2024 | 2023 | 2024 | 2023 | ||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||
Net income (loss) attributable to |
$ | 195 | $ | (3,468) | $ | (6,099) | $ | (9,111) | |||
Depreciation and amortization | 1,545 | 1,786 | 3,134 | 3,583 | |||||||
Loss from equity method investments | 557 | 515 | 1,090 | 1,030 | |||||||
Interest and finance expense | 146 | (7) | 296 | 18 | |||||||
Accretion of lease liability for exited lease | 76 | - | 76 | - | |||||||
State and local franchise taxes | 12 | 23 | 24 | 44 | |||||||
Stock-based compensation | 42 | 65 | 186 | 122 | |||||||
Gain on the sale of assets | (3,801) | (351) | (3,801) | (351) | |||||||
Gain on lease termination | - | (445) | - | (445) | |||||||
Asset impairment | 1,188 | 100 | 3,483 | 100 | |||||||
Losses from discontinued businesses | - | 495 | - | 1,728 | |||||||
Adjusted EBITDA | $ | (40) | $ | (1,287) | $ | (1,611) | $ | (3,282) | |||
Source: Xcel Brands, Inc